Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Alegría-Baños JA, Jiménez-López JC, Vergara-Castañeda A, de León DFC, Mohar-Betancourt A, Pérez-Montiel D, Sánchez-Domínguez G, García-Villarejo M, Olivares-Pérez C, Hernández-Constantino Á, González-Santiago A, Clara-Altamirano M, Arela-Quispe L, Prada-Ortega D. Alegría-Baños JA, et al. Among authors: mohar betancourt a. J Ovarian Res. 2021 Jul 19;14(1):96. doi: 10.1186/s13048-021-00845-6. J Ovarian Res. 2021. PMID: 34275472 Free PMC article.
High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study.
Cantú de León D, Pérez-Montiel D, Villavicencio V, García Carranca A, Mohar Betancourt A, Acuña-Alonzo V, López-Tello A, Vargas-Alarcón G, Barquera R, Yu N, Yunis EJ, Granados J. Cantú de León D, et al. BMC Cancer. 2009 Feb 5;9:48. doi: 10.1186/1471-2407-9-48. BMC Cancer. 2009. PMID: 19196481 Free PMC article.
Cervical Cancer in Young Women: Do They Have a Worse Prognosis? A Retrospective Cohort Analysis in a Population of Mexico.
Isla-Ortiz D, Palomares-Castillo E, Mille-Loera JE, Ramírez-Calderón N, Mohar-Betancourt A, Meneses-García AA, Reynoso-Noverón N. Isla-Ortiz D, et al. Among authors: mohar betancourt a. Oncologist. 2020 Sep;25(9):e1363-e1371. doi: 10.1634/theoncologist.2019-0902. Epub 2020 May 28. Oncologist. 2020. PMID: 32390238 Free PMC article.
Cost-effectiveness of the 21-gene breast cancer assay in Mexico.
Bargalló-Rocha JE, Lara-Medina F, Pérez-Sánchez V, Vázquez-Romo R, Villarreal-Garza C, Martínez-Said H, Shaw-Dulin RJ, Mohar-Betancourt A, Hunt B, Plun-Favreau J, Valentine WJ. Bargalló-Rocha JE, et al. Adv Ther. 2015 Mar;32(3):239-53. doi: 10.1007/s12325-015-0190-8. Epub 2015 Mar 5. Adv Ther. 2015. PMID: 25740550
[Associated factors for women's non-compliance for cervical cancer screening].
Hernández-Hernández DM, Linaldi-Yépez F, Apresa-García T, Escudero-de los Ríos P, Alvarado-Cabrero I, Ornelas-Bernal LA, Mohar-Betancourt A. Hernández-Hernández DM, et al. Rev Med Inst Mex Seguro Soc. 2007 Jul-Aug;45(4):313-20. Rev Med Inst Mex Seguro Soc. 2007. PMID: 17949568 Spanish.
[Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico].
Arce-Salinas C, Lara-Medina FU, Alvarado-Miranda A, Castañeda-Soto N, Bargalló-Rocha E, Ramírez-Ugalde MT, Pérez-Sánchez V, Rivera L, Gambo-Vignole C, Santamaría-Galicia J, Nieves-Casas RI, Morán-Muñoz H, Mohar-Betancourt A. Arce-Salinas C, et al. Rev Invest Clin. 2012 Jan-Feb;64(1):9-16. Rev Invest Clin. 2012. PMID: 22690524 Spanish.
55 results